{"id":58607,"date":"2023-12-19T16:07:08","date_gmt":"2023-12-19T15:07:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/"},"modified":"2023-12-19T16:07:08","modified_gmt":"2023-12-19T15:07:08","slug":"ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/","title":{"rendered":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions"},"content":{"rendered":"<div>\n<p>BERWYN, Pa.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ascellahealth.com%2F&amp;esheet=53872569&amp;newsitemid=20231219412911&amp;lan=en-US&amp;anchor=AscellaHealth&amp;index=1&amp;md5=d81e7a00dc8d92db8a456558d5592b3e\" rel=\"nofollow noopener\" shape=\"rect\">AscellaHealth<\/a>, a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.4merit.co.uk%2F&amp;esheet=53872569&amp;newsitemid=20231219412911&amp;lan=en-US&amp;anchor=4Merit&amp;index=2&amp;md5=ae264939cc8a4fe41862bfebc74eaebf\" rel=\"nofollow noopener\" shape=\"rect\">4Merit<\/a>, a dedicated provider of exceptional outsourced services to the UK government. This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public organizations around the world.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/5\/4Merit_Logo2_12623_APPROVED-06.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/5\/4Merit_Logo2_12623_APPROVED-06.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/22\/4Merit_Logo2_12623_APPROVED-06.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1838529\/5\/Rebrand_New_AH_Logo_2023.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1838529\/21\/Rebrand_New_AH_Logo_2023.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1838529\/5\/Rebrand_New_AH_Logo_2023.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1838529\/22\/Rebrand_New_AH_Logo_2023.jpg\"><\/a><\/p>\n<p>\n\u201cThis strategic collaboration brings together our collective strengths and expertise to establish a new enterprise that delivers innovative healthcare solutions aligned seamlessly with values-based government outsourcing,\u201d says Dea Belazi, president and CEO, AscellaHealth. \u201c4Merit Solutions reflects our shared commitment to providing unparalleled services to governments and public entities worldwide. Leveraging our combined capabilities will have a positive impact on the communities we serve.\u201d<\/p>\n<p>\nThe synergy between these organizations allows 4Merit Solutions to pool resources, share knowledge, and collectively address the unique challenges faced by governments and public organizations.<\/p>\n<p>\n\u201c4Merit Solutions aspires to establish exemplary standards in delivering efficient, secure and transparent solutions across various industries and public service sectors, such as justice, immigration, health, transport and defense,\u201d says Colin Dobell, CEO, 4Merit. \u201cOur alignment with AscellaHealth allows us to tap into deep bench healthcare and pharmaceutical experience across various functions, to provide a wide range of healthcare services to governments and public entities.\u201d<\/p>\n<p>\n<b>About AscellaHealth LLC<\/b><\/p>\n<p>\nAscellaHealth, a global healthcare and specialty pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and\/or cell and gene therapies. A recipient of numerous industry awards for innovation, including Deloitte Technology Fast 500\u2122 and Inc. 5000, AscellaHealth\u2019s customized, patient-centric approach is built upon proprietary technology processes for end-to-end solutions to streamline the commercialization of specialty medications and proactively address unmet client needs, optimize clinical health outcomes and improve the quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.AscellaHealth.com&amp;esheet=53872569&amp;newsitemid=20231219412911&amp;lan=en-US&amp;anchor=www.AscellaHealth.com&amp;index=3&amp;md5=32dbb595ff9bb0052a1acfff421f4bc2\" rel=\"nofollow noopener\" shape=\"rect\">www.AscellaHealth.com<\/a>.<\/p>\n<p>\n<b>About 4Merit<\/b><\/p>\n<p>\nEstablished in 2021, 4Merit is a dedicated provider of exceptional outsourced services to the UK government. 4Merit specializes in immigration services, secure care, protected transport, and security services, all driven by a public service ethos, delivering excellence to serve the greater public good. Our top-tier expertise and core values such as transparency, a passion for public service and commitment to social responsibility are at the foundation of all we do, creating a collaborative environment for all stakeholders to join in our success.<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.4merit.co.uk%2F&amp;esheet=53872569&amp;newsitemid=20231219412911&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.4merit.co.uk%2F&amp;index=4&amp;md5=f692f772385dd15849121734009fffbf\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.4merit.co.uk\/<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media:<\/b><br \/>Nicole Dufour<br \/>\n<br \/>CPR Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x6e;&#100;&#117;f&#x6f;&#x75;&#x72;&#64;&#99;p&#x72;&#x6f;&#x6e;&#108;&#105;n&#x65;&#x2e;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#110;d&#x75;f&#x6f;u&#x72;&#64;&#x63;&#112;&#x72;&#111;&#x6e;&#108;&#x69;&#110;e&#46;c&#x6f;m<\/a><br \/>201.641.1911 x 54<\/p>\n<p><b>Marketing:<\/b><br \/>Darcey McDermott, Chief Marketing &amp; Communications Officer<br \/>\n<br \/>AscellaHealth<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x64;&#x61;r&#x63;&#101;y&#x2e;&#109;&#x63;&#100;e&#x72;&#109;o&#x74;&#116;&#x40;&#97;s&#x63;&#101;&#x6c;&#x6c;a&#x68;&#101;a&#x6c;&#116;&#x68;&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#100;&#x61;&#114;&#x63;e&#x79;&#46;&#109;&#x63;&#100;&#x65;r&#x6d;o&#116;&#x74;&#64;&#x61;s&#x63;e&#108;&#x6c;&#97;&#x68;e&#x61;l&#116;&#x68;&#46;&#x63;o&#x6d;<\/a><br \/>877.389.9040<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERWYN, Pa.&#8211;(BUSINESS WIRE)&#8211;AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit, a dedicated provider of exceptional outsourced services to the UK government. This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58607","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BERWYN, Pa.&#8211;(BUSINESS WIRE)&#8211;AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit, a dedicated provider of exceptional outsourced services to the UK government. This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-19T15:07:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions\",\"datePublished\":\"2023-12-19T15:07:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231219412911\\\/en\\\/1973647\\\/21\\\/4Merit_Logo2_12623_APPROVED-06.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/\",\"name\":\"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231219412911\\\/en\\\/1973647\\\/21\\\/4Merit_Logo2_12623_APPROVED-06.jpg\",\"datePublished\":\"2023-12-19T15:07:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231219412911\\\/en\\\/1973647\\\/21\\\/4Merit_Logo2_12623_APPROVED-06.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231219412911\\\/en\\\/1973647\\\/21\\\/4Merit_Logo2_12623_APPROVED-06.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/","og_locale":"en_US","og_type":"article","og_title":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend","og_description":"BERWYN, Pa.&#8211;(BUSINESS WIRE)&#8211;AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit, a dedicated provider of exceptional outsourced services to the UK government. This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/","og_site_name":"Pharma Trend","article_published_time":"2023-12-19T15:07:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions","datePublished":"2023-12-19T15:07:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/"},"wordCount":450,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/","url":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/","name":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg","datePublished":"2023-12-19T15:07:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231219412911\/en\/1973647\/21\/4Merit_Logo2_12623_APPROVED-06.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ascellahealth-announces-strategic-global-joint-venture-forming-4merit-solutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58607"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58607\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}